BDWM
ALXN

Brewin Dolphin Wealth Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Brewin Dolphin Wealth Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-24
Closed -$2.75K – 320
2020
Q3 		$2.75K Buy
+24
New +$2.75K ﹤0.01% 281